3/20
06:58 am
vrtx
My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]
Low
Report
My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]
3/19
09:29 pm
vrtx
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]
Low
Report
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]
3/18
09:44 am
vrtx
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]
Low
Report
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]
3/18
09:33 am
vrtx
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
3/18
08:43 am
vrtx
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
3/15
09:44 pm
vrtx
Is Vertex Pharmaceuticals Heading to $600? [Yahoo! Finance]
Low
Report
Is Vertex Pharmaceuticals Heading to $600? [Yahoo! Finance]
3/14
08:40 pm
vrtx
Vertex Data Sharpen Focus On Kidney And Pain Revenue Mix [Yahoo! Finance]
Low
Report
Vertex Data Sharpen Focus On Kidney And Pain Revenue Mix [Yahoo! Finance]
3/13
12:14 pm
vrtx
This Stock Just Jumped By 8%: Is It Too Late to Buy? [Yahoo! Finance]
Low
Report
This Stock Just Jumped By 8%: Is It Too Late to Buy? [Yahoo! Finance]
3/13
10:06 am
vrtx
2 Reasons to Watch VRTX and 1 to Stay Cautious [Yahoo! Finance]
Low
Report
2 Reasons to Watch VRTX and 1 to Stay Cautious [Yahoo! Finance]
3/12
01:03 pm
vrtx
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
3/12
10:41 am
vrtx
AM Best Affirms Credit Ratings of Torreyana Insurance Company, Inc. [Yahoo! Finance]
Low
Report
AM Best Affirms Credit Ratings of Torreyana Insurance Company, Inc. [Yahoo! Finance]
3/11
02:57 pm
vrtx
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
3/11
11:30 am
vrtx
Vertex Pharmaceuticals (VRTX) had its price target raised by Truist Financial Corporation from $490.00 to $525.00. They now have a "buy" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) had its price target raised by Truist Financial Corporation from $490.00 to $525.00. They now have a "buy" rating on the stock.
3/10
06:57 pm
vrtx
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today [Yahoo! Finance]
3/10
04:28 pm
vrtx
Stocks hold steady as Wall Street waits for the next signal on how long war with Iran may last [Los Angeles Times (CA)]
Low
Report
Stocks hold steady as Wall Street waits for the next signal on how long war with Iran may last [Los Angeles Times (CA)]
3/10
02:18 pm
vrtx
This Pharmaceutical Stock Is Leading the S&P 500 Higher Tuesday, After 'Remarkable' Trial Results [Yahoo! Finance]
Low
Report
This Pharmaceutical Stock Is Leading the S&P 500 Higher Tuesday, After 'Remarkable' Trial Results [Yahoo! Finance]
3/10
02:18 pm
vrtx
Vertex to seek approval of IgAN drug after Phase III success [Yahoo! Finance]
Low
Report
Vertex to seek approval of IgAN drug after Phase III success [Yahoo! Finance]
3/10
01:02 pm
vrtx
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/10
12:34 pm
vrtx
Vertex Pharmaceuticals (VRTX) had its price target raised by Morgan Stanley from $570.00 to $596.00. They now have an "overweight" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) had its price target raised by Morgan Stanley from $570.00 to $596.00. They now have an "overweight" rating on the stock.
3/10
12:33 pm
vrtx
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing [Yahoo! Finance]
Low
Report
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing [Yahoo! Finance]
3/10
11:26 am
vrtx
Vertex Pharmaceuticals (VRTX) had its price target raised by Bank of America Corporation from $571.00 to $598.00. They now have a "buy" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) had its price target raised by Bank of America Corporation from $571.00 to $598.00. They now have a "buy" rating on the stock.
3/10
11:02 am
vrtx
Vertex Pharmaceuticals (VRTX) had its price target raised by Citigroup Inc. from $575.00 to $585.00. They now have a "buy" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) had its price target raised by Citigroup Inc. from $575.00 to $585.00. They now have a "buy" rating on the stock.
3/10
10:56 am
vrtx
Vertex passes key test In quest to treat kidney diseases [CNBC]
Low
Report
Vertex passes key test In quest to treat kidney diseases [CNBC]
3/10
09:00 am
vrtx
Vertex Pharmaceuticals (VRTX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $580.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $580.00 price target on the stock.
3/10
08:43 am
vrtx
Vertex Pharmaceuticals (VRTX) had its price target raised by Oppenheimer Holdings, Inc. from $540.00 to $600.00. They now have an "outperform" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) had its price target raised by Oppenheimer Holdings, Inc. from $540.00 to $600.00. They now have an "outperform" rating on the stock.